1. Characterization of the cholesterol biosynthetic pathway in Dioscorea transversa.
- Author
-
Salisbury LJ, Fletcher SJ, Stok JE, Churchman LR, Blanchfield JT, and De Voss JJ
- Subjects
- Australia, Cytochrome P450 Family 51 genetics, Cytochrome P450 Family 51 isolation & purification, Cytochrome P450 Family 51 metabolism, Oxidoreductases metabolism, Saccharomyces cerevisiae genetics, Saponins biosynthesis, Saponins genetics, Transcriptome, Cholesterol biosynthesis, Dioscorea classification, Dioscorea enzymology, Dioscorea genetics, Phytosterols biosynthesis, Phytosterols chemistry, Phytosterols genetics
- Abstract
Cholesterol is the precursor of bioactive plant metabolites such as steroidal saponins. An Australian plant, Dioscorea transversa, produces only two steroidal saponins: 1β-hydroxyprotoneogracillin and protoneogracillin. Here, we used D. transversa as a model in which to elucidate the biosynthetic pathway to cholesterol, a precursor to these compounds. Preliminary transcriptomes of D. transversa rhizome and leaves were constructed, annotated, and analyzed. We identified a novel sterol side-chain reductase as a key initiator of cholesterol biosynthesis in this plant. By complementation in yeast, we determine that this sterol side-chain reductase reduces Δ
24,28 double bonds required for phytosterol biogenesis as well as Δ24,25 double bonds. The latter function is believed to initiate cholesterogenesis by reducing cycloartenol to cycloartanol. Through heterologous expression, purification, and enzymatic reconstitution, we also demonstrate that the D. transversa sterol demethylase (CYP51) effectively demethylates obtusifoliol, an intermediate of phytosterol biosynthesis and 4-desmethyl-24,25-dihydrolanosterol, a postulated downstream intermediate of cholesterol biosynthesis. In summary, we investigated specific steps of the cholesterol biosynthetic pathway, providing further insight into the downstream production of bioactive steroidal saponin metabolites., Competing Interests: Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article., (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF